170900.KS
Dong-A ST Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 36,900.00
−0.54%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 860.9B | 808.8B | 697.9B | 664.0B | 635.4B |
| Cost of Revenue | 485.0B | 452.3B | 357.7B | 341.8B | 320.0B |
| Gross Profit | 375.9B | 356.5B | 340.2B | 322.2B | 315.4B |
| Operating Expenses | |||||
| R&D Expense | 116.3B | 120.8B | 131.5B | 105.5B | 88.2B |
| SG&A Expense | 137.1B | 105.8B | 99.3B | 95.2B | 101.0B |
| General & Admin Expense | 37.2B | 51.3B | 51.0B | 49.5B | 39.9B |
| Selling & Marketing Expense | 39.2B | 54.4B | 48.3B | 45.7B | 61.1B |
| Other Expenses | 126.5B | 129.3B | 134.4B | 116.2B | 109.1B |
| Total Operating Expenses | 350.6B | 355.9B | 365.2B | 307.0B | 298.2B |
| Cost and Expenses | 835.6B | 808.2B | 722.9B | 652.8B | 618.2B |
| Operating Income (EBIT) | 25.3B | 618.3M | (25.0B) | 11.2B | 16.7B |
| Non-Operating | |||||
| Interest Income | 42.1B | 4.9B | 9.6B | 9.2B | 2.8B |
| Interest Expense | 30.3B | 21.0B | 21.2B | 12.7B | 8.1B |
| Net Interest Income | 11.8B | (16.1B) | (11.6B) | (3.5B) | (5.3B) |
| Other Non-Op Income/Expense | (13.5B) | (41.9B) | 3.6B | (3.6B) | (8.5B) |
| Non-Operating Income (excl Interest) | 20.9B | — | (24.8B) | (7.5B) | (2.5B) |
| EBT (Pre-Tax Income) | 11.8B | (41.2B) | (21.4B) | 7.6B | 17.5B |
| Income Tax Expense | 11.7B | (3.6B) | 1.8B | 4.0B | 4.7B |
| Bottom Line | |||||
| Net Income | 2.9B | (28.6B) | (1.2B) | 11.1B | 13.6B |
| Earnings from Cont. Ops | 68.0M | (37.6B) | (22.0B) | 3.6B | 12.8B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (6.1B) | (28.6B) | (1.2B) | 12.8B | 13.6B |
| Per Share | |||||
| Basic EPS | (₩611) | (₩2,971) | (₩141) | ₩1,474 | ₩1,544 |
| Diluted EPS | (₩654) | (₩2,971) | (₩141) | ₩1,254 | ₩1,402 |
| Revenue Per Share | ₩89,282 | ₩84,841 | ₩80,688 | ₩76,701 | ₩72,389 |
| Shares | |||||
| Basic Shares Outstanding | 9.6M | 9.5M | 8.6M | 8.7M | 8.8M |
| Diluted Shares Outstanding | 9.6M | 9.5M | 8.6M | 10.2M | 10.2M |
| Profitability Metrics | |||||
| EBITDA | (36.3B) | 33.4B | 29.0B | 45.1B | 49.4B |
| D&A | 31.3B | 32.8B | 29.1B | 26.3B | 20.8B |
| EBIT | (67.6B) | 618.3M | (153.4M) | 18.7B | 28.5B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026